ANEB

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) is a clinical-stage biotechnology company founded in 2020 and based in Lakeway, Texas. The company went public in May 2021 and focuses on developing treatments for acute cannabinoid intoxication and substance addiction disorders. As a pre-revenue biotech company, Anebulo is currently advancing its lead drug candidate through clinical trials while seeking to address the growing public health concerns related to cannabis overdoses and addiction.